Search General Info
Search Education
Search Partnering Companies
Macro Biologics
3:15 PM - 3:30 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104C
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
Macro Biologics’ innovative technology platform creates synthetic biological polymers (macro biologics) for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials safe for the environment. Our first class of synthetic macro biologics, Amicidins, combine a beneficial physical mode-of-action (barrier or surfactant) and broad microbicidal mode-of-action, including against antibiotic resistant bacteria. Their composition (amino acids), size, and self-assembly into multimers, yield a high level of performance and safety when applied to exposed tissues. Our first focus is prevention and treatment of life-threating infections in surgery & trauma – INDs are in preparation for Amicidin-α Surgical and Amicidin-β Solution; human clinical trials are expected to follow. Going forward, we anticipate Amicidins will go into a wide variety of products ranging from human therapeutics and devices to veterinary medicine / pet care to consumer health and cosmetics.
![](https://www.abstractscorecard.com/uploads/Tasks/upload/20525/EOISBJNL-1511329-1-JPG.png)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2011
Main Therapeutic Focus:
Infectious Diseases
Lead Product in Development:
Macro Biologics has four products in development: Amicidin-alpha Surgical, Amicidin-alpha PFC (Prolonged Field Care), Amicidin-beta Solution, and Amicidin-beta/EF (Extended Formulation).
Amicidin-alpha Surgical is designed to prevent infection, as an adjunct to surgical procedures. It combines physical barrier to block and microbicidal activity to kill.
Amicidin-alpha PFC (supported by U.S. DoD) is designed for prolonged field care of injured warfighters. It is a dry powder formulation designed to protect wounds for up to 72h.
Amicidin-beta Solution (supported by CARB-X) is designed to treat infection, as an adjunct to surgical procedures. It combines surfactant activity to cleanse with microbicidal activity to kill.
Amicidin-beta/EF (supported by UK GAMRIF & CARB-X) is designed for traumatic wounds and emergency caesarean delivery, including in low- and middle-income countries.
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
![](https://www.conferenceharvester.com/uploads/harvester/photos/XDQDGWMO-Presenter-BevilacquaM.png)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved